Data from the Star trial of AngioDynamics‘ (NSDQ:ANGO) NanoKnife minimally invasive soft tissue ablation device showed it may prolong the lifespan of pancreatic cancer patients. The study has been published in the Annals of Surgery, according to AngioDynamics. The 200-patient trial examined individuals with locally advanced pancreatic cancer treated with irreversible electroporation with the NanoKnife. Of the […]
AngioDynamics
AngioDynamics launches AngioVac study
AngioDynamics (NSDQ:ANGO) said yesterday it enrolled the 1st patient in a new database analysis of patients treated with its AngioVac system. The Rapid database will evaluate patterns of use, safety and effectiveness data for patients treated with the AngioVac system to remove fresh, soft thrombi or emboli, the Albany, N.Y.-based company said. “So far, we have centers […]
AngioDynamics launches BioFlo midline cath
AngioDynamics (NSDQ:ANGO) said today it launched the BioFlo Midline catheter, indicated for short-term intravenous therapies. Albany, N.Y.-based AngioDynamics won FDA 510(k) clearance for the BioFlo earlier this year, the company said. Midline catheters provide intravenous access for up to 30 days, longer than peripheral intravenous catheters which need to be replaced every few days, the company […]
Biolitec takes $75m AngioDynamics beef to the Supremes
German medical laser maker Biolitec (ETR:BIB) asked the U.S. Supreme Court this month to review an appeals court decision upholding a $75 million contempt penalty in its longtime legal dispute with AngioDynamics (NSDQ:ANGO). Judge Michael Ponsor of the U.S. District Court for Massachusetts slapped Biolitec with a $75 million ruling last year, after finding that it deliberately effected a so-called […]